Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study.

ABSTRACT:

Objectives

Patients with various inflammatory rheumatic diseases (IRDs) have increased risk of atherothrombotic disease. Lipoprotein (a) (Lp(a)) is a risk factor for atherosclerosis but its role in IRD with accompanying coronary artery disease (CAD) is still unclear. We aimed to examine if serum Lp(a) levels differed between CAD patients with and without accompanying IRD.

Design

A cross-sectional observational, patient-based cohort study.

Setting

Referred centre for coronary artery bypass grafting in the South Eastern part of Norway.

Participants

67 CAD patients with IRD (CAD/IRD) and 52 CAD patients without IRD (CAD/non-IRD). All patients were Caucasians, aged >18 years, without any clinically significant infection or malignancy.

Methods

Lp(a) levels in

SUBMITTER: Holm S 

PROVIDER: S-EPMC6530453 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature